Director New Business Development Drug Substance

The Siegfried Group is a global life science company with a network of 13 sites in Europe, the USA, and Asia. Siegfried offers contract development and manufacturing of active pharmaceutical ingredients, intermediates, and drug products and has sales more than CHF 1.3 billion Swiss Franks. Siegfried Holding AG employs over 3,800 people and is listed on the SIX Swiss Exchange (SIX: SFZN).

Purpose of Position

This role is strategically important to our company's mission. You will be key to continuing our remarkable growth story by expanding an already robust & diverse client base of innovator companies. This is an opportunity for an individual to step up to a Director role and join a leader in the growing CDMO industry. Expect to grow here!

Your role

New Business

• The target customers include emerging, mid-size and large Pharma companies possessing preclinical-late-stage clinical development projects and commercial products comprised of API(s) & advanced intermediates.

• Take ownership of new customer /contact prospecting within North America, presenting Siegfried’s worldwide technical capabilities with a focus on drug substance, while also highlighting Siegfried's drug product offerings

• Formulate and implement New Business Development (NBD) strategies based on market research and industry insights

• Engage in Siegfried social marketing activities to raise awareness of company offerings & planned events

• Support client visits to the various sites within Siegfried's global manufacturing network.

Stakeholder Management

• Orchestrate mutual efforts with our global and local departments to grow our business. Plan and align with our customers on their requirements, forecasts and firm orders to help ensure the seamless execution of their new business within our global network

• Work with technical teams to evaluate and assess new projects enabling the preparation & submission of written proposals.

• Develop contracts with new customers (in conjunction with Siegfried departments involved) and remain responsible for their monitoring and compliance.

Your profile

Knowledge and experience

• Minimum of 5 years of sales experience of small molecule Contract Manufacturing services is a must have criteria. A strong understanding of the pharmaceutical manufacturing industry is what we are looking for

• Any further knowledge of the CDMO or API services pharmaceutical industry (Business Development, Sales, R&D, production, project management) will give you an edge

• BSc / MSc / PhD degree in chemistry / natural sciences / chemical engineering / and / or MBA are not required, but viewed favorably

Soft Skills

• The most important requirement is to be driven and possess an entrepreneurial mindset. You love strong teamwork, and are also fully capable to work autonomously to achieve your overall goals

• A high degree of resilience and determination will be needed, as the industry landscape is competitive and requires an individual capable of effectively conveying Siegfried's value proposition.

• You enjoy working with both domestic & international colleagues and offer strong overall communication skills.

• Around 50% travel will be required as part of the role

Working at Siegfried

• Free choice of location paired with remote working

• Flexible working hours

• A generous Employee Stock Purchase Plan

• A generous and stable pension scheme

• Other benefits that tie in with local social security of the location

• We are a growing global company with Swiss roots and 150 years of history

Who we are

In the Midst of People’s Lives – Across the Globe

The Siegfried Group is one of the world’s leading Custom Development and Manufacturing Organizations (CDMOs) developing and producing active pharmaceutical ingredients (API), intermediates and finished dosage forms. As our core competence, we successfully integrate chemical and pharmaceutical capabilities into a single business model.

The Siegfried name stands for highest quality, efficiency, flexibility and safety. Present in Europe, Asia and North America, we serve a broad global customer base from major international pharmaceutical companies down to small biologic-pharmaceutical organizations. For them we develop and produce product innovations on a large scale to finished products. We integrate our offer seamlessly into the customers’ value chain. Our comprehensive services range from early-stage Research & Development services such as synthesis, scale-up, formulation development, stability studies and method development all the way through to manufacturing services, ranging from preclinical R&D material for clinical trial purposes to commercial production.

We are able to produce about 200 of the approximately 1500 registered drug substances used in medicine. Moreover, we produce 20 percent of global demand for caffeine. Consequently, nearly 1 billion individuals come into contact with Siegfried products.

.

General Information